Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

ValiRx (VAL) Share News

ValiRx shares drop as cancer drug sub-licensing progress stalls

17th Jun 2022 10:41

(Alliance News) - ValiRx PLC on Friday said it is expecting to be asked to extend the exclusivity period between itself and TheroemRx Inc regarding the proposed sub-licence of cancer treatment VAL201. Read More

IN BRIEF: ValiRx widens annual loss as R&D costs climb

7th Jun 2022 19:03

ValiRx PLC - Nuneaton, England-based drug development company - Widens pretax loss in 2021 to GBP1.7 million from GBP1.5 million the previous year. Research and development costs rise 32% to GBP303,789 in the year from GBP230,115 a year prior. Total assets at December 31 fall to GBP3.5 million from GBP4.9 million at the end of 2020. Chief Executive Suzanne Dilly says the work completed during 2021 has provided a "strong foundation" for the company moving forward. Read More

FTSE 100 Latest

Value8,824.54

Change-13.37